Physician profile
Tej Kokroo
NPI 1437191798
$911.01
in general payments reported to CMS, 2019-2025
21 companies · $193 in 2025
The $193 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2021: $34.31 · 2022: $189 · 2023: $183 · 2024: $71.41 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404 · Education: $43.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.08 |
| Education | $43.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $113.36 | 2022 | |
| Pfizer INC. | $113.06 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $75.91 | 2024-2025 | Rexulti |
| Medtronic, INC. | $74.84 | 2023 | Endurant Iis |
| Astrazeneca Pharmaceuticals LP | $73.61 | 2019-2025 | Enhertu, Farxiga |
| Astellas Pharma US INC | $72.76 | 2019-2023 | Veozah, Myrbetriq |
| Novartis Pharmaceuticals Corporation | $54.73 | 2019-2023 | |
| Novo Nordisk INC | $50.93 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $37.86 | 2025 | |
| Biotronik INC. | $34.31 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $27.56 | 2022-2025 | Zoryve |
| Corium, LLC | $24.76 | 2023 | Adlarity |
| Bausch Health US, LLC | $22.65 | 2025 | Wellbutrin |
| Exact Sciences Corporation | $18.78 | 2024 | Cologuard Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.66 | 2025 | Caplyta |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18.11 | 2022 | |
| Glaxosmithkline, LLC. | $18.07 | 2023 | Shingrix, Arexvy |
| Inspire Medical Systems, INC. | $16.59 | 2024 | Inspire |
| Janssen Pharmaceuticals, INC | $16.23 | 2019 | |
| Merck Sharp & Dohme LLC | $14.73 | 2019 | |
| Amarin Pharma, INC. | $13.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tej Kokroo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.